SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-023799
Filing Date
2022-02-15
Accepted
2022-02-15 16:18:45
Documents
15
Period of Report
2022-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226818d1_8k.htm   iXBRL 8-K 40031
2 EXHIBIT 10.1 tm226818d1_ex10-1.htm EX-10.1 167377
3 EXHIBIT 99.1 tm226818d1_ex99-1.htm EX-99.1 14305
4 GRAPHIC tm226818d1_ex99-1img001.jpg GRAPHIC 12013
  Complete submission text file 0001104659-22-023799.txt   460108

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hook-20220215.xsd EX-101.SCH 3048
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20220215_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20220215_pre.xml EX-101.PRE 22605
9 EXTRACTED XBRL INSTANCE DOCUMENT tm226818d1_8k_htm.xml XML 3705
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 22639407
SIC: 2834 Pharmaceutical Preparations